Comparison of PENG block and lumbar plexus block in terms of postoperative analgesia and mobilization for fast track primary hip arthroplasty

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507506-14-01

Acronym

fastpeng

Enrollment

Registered

2024-03-15

Start date

2024-05-08

Completion date

Unknown

Last updated

2024-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty

Brief summary

Pain, Quadriceps muscular strength

Detailed description

Adverse effects: Nausea, vomiting, sedation, toxicity, others, Opioid consumption, Need for additional analgesia, Length of hospital stay, Pain experience

Interventions

DRUGSuero Fisiológico Braun 0

DRUG9% disolvente para uso parenteral Cloruro de sodio

DRUGLevobupivacaína Altan 2

DRUG5 mg/ml solución inyectable y para perfusión EFG

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Pain, Quadriceps muscular strength	—

Secondary

Measure	Time frame
Adverse effects: Nausea, vomiting, sedation, toxicity, others, Opioid consumption, Need for additional analgesia, Length of hospital stay, Pain experience	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026